Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
暂无分享，去创建一个
R. Kaiser | S. Novello | M. Krzakowski | J. von Pawel | I. Bondarenko | J. Douillard | M. Reck | B. Gaschler-Markefski | M. Liao | M. Gottfried | J. Barrueco | S. Orlov | A. Mellemgaard | Claudia-Nanette Gann